tuberoinfundibular dopaminergic
TIDA
inhibit
prolactin
PRL
secretion
young
system
acute
elevations
serum
PRL
activity
responsiveness
lost
aging rats
chronically
PRL
levels
study
induce
hyperprolactinemia
rats
extended
periods
effects
dopaminergic systems
brain
Hyperprolactinemia
induced
treatment
haloperidol
dopamine receptor
antagonist
Palkovits' microdissection technique
high-performance liquid chromatography
measure
neurotransmitter
concentrations
brain
months
hyperprolactinemia
dopamine
DA
concentrations
median eminence
ME
increased
control group
months
hyperprolactinemia
increase
DA
concentrations
ME
control group
DA response
hyperprolactinemia
increase
serum
PRL
levels
implantation
MMQ cells
kidney capsule
levels
DA
norepinephrine
NE
serotonin
5-HT
metabolites
arcuate nucleus
AN
medial preoptic area
MPA
caudate putamen
CP
substantia nigra
SN
zona incerta
ZI
decrease
5-hydroxyindoleacetic acid
5-HIAA
AN
6-months
hyperprolactinemia
increase
DA
concentrations
AN
9-months
hyperprolactinemia
results
hyperprolactinemia
TIDA
neurons
effects
duration
intensity
hyperprolactinemia
age-related decrease
hypothalamic
dopamine function
associated with
increases
PRL
secretion
